The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia

Background Metabolic syndrome is a cluster of risk factors that is responsible for the risk of coronary heart disease and stroke. Therefore, the aim of this study was to assess the prevalence of MetS and its components among T2DM patients. Methods A cross-sectional study was conducted at the Diabetes Clinic of the Hospital, from June to July, 2015. Data were entered into EPI INFO software and exported to SPSS 20 for analysis. MetS prevalence was estimated using NCEP ATPIII and IDF criteria. Anthropometric measurements, investigations of serum glucose and lipid profiles were done. Logistic regression analysis was used to evaluate associated factors. A P-value ≤ 0.05 was considered statistically significant. Result A total of 159 participants were included in the study; 119 (59.7%) were females with mean (±SD) age of (49.8±8.7) year. The prevalence of MetS was 66.7% in NCEP-ATP III and 53.5% in IDF definitions. The most prevalent component of MetS was elevated triglyceride (56.6% in ATPIII and 62.3% in IDF criteria), followed by abdominal obesity (61%) IDF and elevated blood pressure (55.4%) NCEP-ATPIII criteria. The regression analysis showed that increased age, being female, high BMI, having diabetes for over 5 years and poor glycemic control were significantly associated with metabolic syndrome. Conclusion The prevalence of MetS and its components among T2DM patients were high, suggesting that diabetic patients are at increased risk of CVD and other complications. Efforts should be geared towards addressing these abnormalities through lifestyle modification, health awareness and medications in order to reduce this complication.

[1]  M. Hoque,et al.  Prevalence of metabolic syndrome in non-obese newly detected Type-2 diabetes Mellitus , 2016 .

[2]  A. Chawla,et al.  Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? , 2016, Indian journal of endocrinology and metabolism.

[3]  J. Adeleye,et al.  THE metabolic syndrome and accurate cardiovascular risk prediction in persons with type 2 diabetes mellitus. , 2016, Diabetes & metabolic syndrome.

[4]  Y. Mesfin,et al.  Prevalence of hypertension in Ethiopia: a systematic meta-analysis , 2015, Public Health Reviews.

[5]  E. Pepić,et al.  Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus , 2015, Medical archives.

[6]  A. Hameed,et al.  Gender difference in components of metabolic syndrome among patients of type 2 diabetes , 2015, Pakistan journal of medical sciences.

[7]  K. Boateng,et al.  Prevalence of metabolic syndrome in type 2 diabetes mellitus patients , 2015, International journal of applied & basic medical research.

[8]  Molla Abebe,et al.  Metabolic syndrome among hypertensive patients at University of Gondar Hospital, North West Ethiopia: a cross sectional study , 2014, BMC Cardiovascular Disorders.

[9]  R. Kafle,et al.  Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria , 2014, Journal of Diabetes & Metabolic Disorders.

[10]  V. Mogre,et al.  Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus , 2014, Journal of Diabetes & Metabolic Disorders.

[11]  Yoke Mun Chan,et al.  Prevalence of metabolic syndrome in type 2 diabetic patients: A comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions , 2013 .

[12]  W. Choi,et al.  Sleep duration and metabolic syndrome in adult populations: a meta-analysis of observational studies , 2013, Nutrition & Diabetes.

[13]  C. Lyles,et al.  Sex Disparities in Diabetes Process of Care Measures and Self-Care in High-Risk Patients , 2013, Journal of Diabetes Research.

[14]  S. Bhattarai,et al.  Prevalence of metabolic syndrome in type 2 diabetes mellitus patients using NCEP/ATP III and IDF criteria in Nepal , 2012 .

[15]  C. Okafor The metabolic syndrome in Africa: Current trends , 2012, Indian journal of endocrinology and metabolism.

[16]  S. Koh,et al.  Association between short sleep duration and high incidence of metabolic syndrome in midlife women. , 2011, The Tohoku journal of experimental medicine.

[17]  T. Lam,et al.  Self-Reported Long Total Sleep Duration Is Associated With Metabolic Syndrome , 2011, Diabetes Care.

[18]  Gregory Kaltsas,et al.  Metabolic syndrome: definitions and controversies , 2011, BMC medicine.

[19]  T. Takebayashi,et al.  Relationship between sleep duration and clustering of metabolic syndrome diagnostic components , 2011, Diabetes, metabolic syndrome and obesity : targets and therapy.

[20]  T. Fukui,et al.  Relation between metabolic syndrome and sleep duration in Japan: a large scale cross-sectional study. , 2011, Internal medicine.

[21]  N. Akpan,et al.  Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in Uyo, Nigeria , 2010 .

[22]  Fessahaye Alemseged,et al.  Risk Factors for Cardiovascular Diseases among Diabetic Patients In Southwest Ethiopia , 2010, Ethiopian journal of health sciences.

[23]  M. Javed,et al.  Frequency of metabolic syndrome in patients with type-2 diabetes. , 2010, Journal of Ayub Medical College, Abbottabad : JAMC.

[24]  D. Whiting,et al.  The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. , 2010, Diabetes research and clinical practice.

[25]  F. Titty Glycaemic control, dyslipidaemia and metabolic syndrome among recently diagnosed diabetes mellitus patients in Tamale Teaching Hospital, Ghana. , 2010, West African journal of medicine.

[26]  T. Sanke,et al.  Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications. , 2008, Diabetes research and clinical practice.

[27]  B. Balkau,et al.  Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. , 2007, Atherosclerosis.

[28]  V. Mohan,et al.  Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34) , 2007, Diabetes/metabolism research and reviews.

[29]  M. Abdul-Ghani,et al.  Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. , 2006, The Israel Medical Association journal : IMAJ.

[30]  E. Tai,et al.  Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. , 2006, Atherosclerosis.

[31]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[32]  M. Ermani,et al.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. , 2006, The Journal of clinical endocrinology and metabolism.

[33]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[34]  J. Tuomilehto,et al.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.

[35]  G. Marchesini,et al.  WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[36]  B. Tomlinson,et al.  Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality , 2001, International Journal of Obesity.

[37]  N. Unwin,et al.  Diabetes in sub-Saharan Africa. , 2001, Advances in experimental medicine and biology.

[38]  P. Deurenberg,et al.  Body mass index and percent body fat: a meta analysis among different ethnic groups , 1998, International Journal of Obesity.